Healthy Aging Program
Head: Roza Adany, MD, PhD
Purpose
The Healthy Aging Program advances translational research aimed at extending healthspan through integrated biological, clinical, and population-level strategies. The program connects geroscience with intervention development, prevention frameworks, and policy-relevant implementation.
Why it matters
• Europe is undergoing rapid demographic aging with escalating burdens of cardiovascular disease, dementia, frailty, and cancer
• Preventable determinants of unhealthy aging remain insufficiently translated into scalable intervention frameworks.
• Bridging geroscience with real-world public health practice is essential to to sustain healthcare systems and preserve functional independence.
What we do
• Preclinical anti-aging research in preclinical models targeting vascular, metabolic, and neurobiological aging pathways
• Advanced transcriptomics and multi-omics pipelines for biomarker discovery and target identification
• Translational clinical studies focused on aging-related risk stratification and intervention testing
• Large-scale epidemiological analyses of determinants of healthy aging
• Cancer survival and aging interaction research
• Retinal epidemiology and vascular aging biomarkers
• Public health genomics and precision prevention
• Integration with the Fodor Center for Prevention and Healthy Aging (Semmelweis University)
• Support for the Semmelweis Study and the Semmelweis-EUniWell Workplace Health Promotion Program
• End-to-end research support: study design, analytics, implementation, and policy translation
Key outputs
• Selected publications (curated list)
• Translational datasets
• Participation in research consortia
• Evidence frameworks for prevention programs
People
• Program Head: Roza Adany, MD, PhD
• Key collaborators: Adam Tabak, MD, PhD, Stefano Tarantini, PhD, Balazs Gyorffy, MD, PhD, Tamas Csipo, MD, Agnes Lipecz MD, Agnes Szappanos MD, Peter Piko PhD, Monika Fekete MD, PhD, Vince Fazekas-Pongor, MD, PhD, David Major, MD, PhD, Hajnalka Andrikovics, MD, PhD , Tamas Kiss, MD, PhD, Dorina Nagy PhD
Collaborate
• We actively build European research consortia and welcome academic, clinical, and public health partners for Horizon proposals and joint initiatives.